UMP Healthcare Holdings Gelecekteki Büyüme

Future kriter kontrolleri 0/6

Şu anda UMP Healthcare Holdings için büyüme ve gelir tahmini yapmak üzere yeterli analist kapsamımız yok.

Anahtar bilgiler

n/a

Kazanç büyüme oranı

n/a

EPS büyüme oranı

Healthcare kazanç büyümesi	15.9%
Gelir büyüme oranı	n/a
Gelecekteki özkaynak getirisi	n/a
Analist kapsamı	None
Son güncelleme	n/a

Gelecekteki son büyüme güncellemeleri

Recent updates

UMP Healthcare Holdings (HKG:722) Is Paying Out Less In Dividends Than Last Year

Mar 02

UMP Healthcare Holdings (HKG:722) Is Due To Pay A Dividend Of HK$0.03

Dec 01

UMP Healthcare Holdings (HKG:722) Is Due To Pay A Dividend Of HK$0.03

Oct 26

UMP Healthcare Holdings (HKG:722) Is Due To Pay A Dividend Of HK$0.03

Sep 24

UMP Healthcare Holdings (HKG:722) Will Pay A Larger Dividend Than Last Year At HK$0.017

Feb 26

UMP Healthcare Holdings (HKG:722) Is Increasing Its Dividend To HK$0.03

Nov 16

UMP Healthcare Holdings (HKG:722) Will Pay A Larger Dividend Than Last Year At HK$0.03

Oct 26

UMP Healthcare Holdings (HKG:722) Is Increasing Its Dividend To HK$0.03

Sep 26

Here's What To Make Of UMP Healthcare Holdings' (HKG:722) Decelerating Rates Of Return

May 13

UMP Healthcare Holdings (HKG:722) Is Paying Out A Larger Dividend Than Last Year

Feb 27

UMP Healthcare Holdings (HKG:722) Is Increasing Its Dividend To HK$0.028

Nov 27

We Think UMP Healthcare Holdings Limited's (HKG:722) CEO Compensation Package Needs To Be Put Under A Microscope

Nov 19

Investors Can Find Comfort In UMP Healthcare Holdings' (HKG:722) Earnings Quality

Oct 29

UMP Healthcare Holdings' (HKG:722) Dividend Will Be Increased To HK$0.028

Oct 12

UMP Healthcare Holdings (HKG:722) Is Increasing Its Dividend To HK$0.028

Sep 25

UMP Healthcare Holdings (HKG:722) Might Be Having Difficulty Using Its Capital Effectively

Jul 27

A Look At The Fair Value Of UMP Healthcare Holdings Limited (HKG:722)

Apr 29

Bu bölümde, yatırımcıların şirketin kâr elde etme kabiliyetini anlamalarına yardımcı olmak için genellikle profesyonel analistlerin fikir birliği tahminlerine dayanan gelir ve kazanç büyüme tahminlerini sunuyoruz. Ancak UMP Healthcare Holdings yeterli geçmiş veri sağlamadığından ve analist tahmini olmadığından, gelecekteki kazançları geçmiş verileri ekstrapole ederek veya analist tahminlerini kullanarak güvenilir bir şekilde hesaplanamaz.

SimplyWall St tarafından kapsanan şirketlerin %97'si geçmiş finansal verilere sahip olduğu için bu oldukça nadir bir durumdur.

Kazanç ve Gelir Büyüme Tahminleri

SEHK:722 - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (HKD Millions )
Tarih	Gelir	Kazançlar	Serbest Nakit Akışı	Faaliyetlerden Nakit	Avg. Analist Sayısı
6/30/2024	750	41	92	149	N/A
3/31/2024	744	37	86	166	N/A
12/31/2023	739	34	81	183	N/A
9/30/2023	733	47	81	187	N/A
6/30/2023	728	60	81	190	N/A
3/31/2023	700	64	N/A	N/A	N/A
12/31/2022	673	68	84	168	N/A
9/30/2022	670	70	55	139	N/A
6/30/2022	666	71	26	111	N/A
3/31/2022	671	72	N/A	N/A	N/A
12/31/2021	676	73	123	162	N/A
9/30/2021	647	74	135	167	N/A
6/30/2021	617	74	147	173	N/A
3/31/2021	584	66	93	121	N/A
12/31/2020	551	59	40	69	N/A
9/30/2020	555	59	68	98	N/A
6/30/2020	559	59	96	128	N/A
3/31/2020	587	67	103	132	N/A
12/31/2019	615	75	110	137	N/A
9/30/2019	593	44	71	92	N/A
6/30/2019	570	13	32	47	N/A
3/31/2019	540	8	N/A	N/A	N/A
12/31/2018	509	3	-27	35	N/A
9/30/2018	487	20	-62	31	N/A
6/30/2018	466	38	-98	26	N/A
3/31/2018	475	48	N/A	N/A	N/A
12/31/2017	485	59	N/A	34	N/A
9/30/2017	501	51	N/A	34	N/A
6/30/2017	516	44	N/A	35	N/A
3/31/2017	504	23	N/A	45	N/A
12/31/2016	491	2	N/A	54	N/A
9/30/2016	475	4	N/A	40	N/A
6/30/2016	458	7	N/A	25	N/A
3/31/2016	441	17	N/A	14	N/A
12/31/2015	424	28	N/A	2	N/A
9/30/2015	414	35	N/A	23	N/A
6/30/2015	403	41	N/A	44	N/A
6/30/2014	355	42	N/A	44	N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: 722 'un tahmini kazanç büyümesinin tasarruf oranının ( 2.4% ) üzerinde olup olmadığını belirlemek için yeterli veri yok.

Kazançlar ve Piyasa: 722 'un kazançlarının Hong Kong pazarından daha hızlı büyümesinin öngörülüp öngörülmediğini belirlemek için yeterli veri yok

Yüksek Büyüme Kazançları: 722 şirketinin kazançlarının önümüzdeki 3 yıl içerisinde önemli ölçüde artıp artmayacağını belirlemek için yeterli veri bulunmuyor.

Gelir ve Pazar: 722 şirketinin gelirinin Hong Kong pazarından daha hızlı büyüyeceğinin tahmin edilip edilmediğini belirlemek için yeterli veri yok.

Yüksek Büyüme Geliri: 722 şirketinin gelirinin yıllık 20% oranından daha hızlı artacağının tahmin edilip edilmediğini belirlemek için yeterli veri yok.

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: 722 'un Özsermaye Getirisi'nin 3 yıl içinde yüksek olmasının öngörülüp öngörülmediğini belirlemek için yeterli veri yok

Büyüyen şirketleri keşfedin

Şirket Analizi ve Finansal Veri Durumu

Veri	Son Güncelleme (UTC saati)
Şirket Analizi	2025/02/15 17:28
Gün Sonu Hisse Fiyatı	2025/02/14 00:00
Kazançlar	2024/06/30
Yıllık Kazançlar	2024/06/30

Veri Kaynakları

Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.

Paket	Veri	Zaman Çerçevesi	Örnek ABD Kaynağı ^*
Şirket Finansalları	10 yıl	Gelir tablosu Nakit akış tablosu Bilanço	SEC Form 10-K SEC Form 10-Q
Analist Konsensüs Tahminleri	+3 yıl	Finansal tahminler Analist fiyat hedefleri	Analist Araştırma Raporları Blue Matrix
Piyasa Fiyatları	30 yıl	Hisse senedi fiyatları Temettüler, Bölünmeler ve Eylemler	ICE Piyasa Verileri SEC Form S-1
Sahiplik	10 yıl	En büyük hissedarlar İçeriden öğrenenlerin ticareti	SEC Form 4 SEC Form 13D
Yönetim	10 yıl	Liderlik ekibi Yönetim Kurulu	SEC Form 10-K SEC Form DEF 14A
Önemli Gelişmeler	10 yıl	Şirket duyuruları	SEC Form 8-K

* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılmıştır.

Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Daha fazla bilgi edinin.

Analiz Modeli ve Kar Tanesi

Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntıları Github sayfamızda mevcuttur, ayrıca raporlarımızın nasıl kullanılacağına dair kılavuzlarımız ve Youtube'da eğitimlerimiz bulunmaktadır.

Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.

Endüstri ve Sektör Metrikleri

Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları Github'da mevcuttur.

Analist Kaynakları

UMP Healthcare Holdings Limited 2 Bu analistlerden 0, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.

Analist	Kurum
Kam Wai Kwok	CGS International
Geng Chen	Phillip Securities (HK)

UMP Healthcare Holdings Gelecekteki Büyüme

Future kriter kontrolleri 0/6

Anahtar bilgiler

Gelecekteki son büyüme güncellemeleri

UMP Healthcare Holdings Limited Provides Financial Guidance for Fiscal Year 2022

Recent updates

Upcoming dividend of HK$0.02 per share

UMP Healthcare Holdings Limited Approves A Final Dividend for the Year Ended 30 June 2024

UMP Healthcare Holdings (HKG:722) Is Due To Pay A Dividend Of HK$0.02

There May Be Some Bright Spots In UMP Healthcare Holdings' (HKG:722) Earnings

Full year 2024 earnings released: EPS: HK$0.051 (vs HK$0.077 in FY 2023)

UMP Healthcare Holdings (HKG:722) Will Pay A Dividend Of HK$0.02

Independent Non-Executive Director recently bought HK$178k worth of stock

Independent Non-Executive Director recently bought HK$152k worth of stock

UMP Healthcare Holdings (HKG:722) Is Due To Pay A Dividend Of HK$0.02

Final dividend reduced to HK$0.02

Full year 2024 earnings released: EPS: HK$0.051 (vs HK$0.077 in FY 2023)

UMP Healthcare Holdings Limited, Annual General Meeting, Nov 29, 2024

UMP Healthcare Holdings Limited Proposes Final Cash Dividend for the Year Ended 30 June 2024, Payable on 10 January 2025

UMP Healthcare Holdings Limited to Report Fiscal Year 2024 Results on Sep 25, 2024

Co-CEO & Executive Vice Chairman recently bought HK$83k worth of stock

Executive Chairman recently bought HK$58k worth of stock

First half 2024 earnings released: EPS: HK$0.02 (vs HK$0.054 in 1H 2023)

Upcoming dividend of HK$0.013 per share

Executive Chairman recently bought HK$60k worth of stock

UMP Healthcare Holdings (HKG:722) Is Paying Out Less In Dividends Than Last Year

First half dividend reduced to HK$0.013

UMP Healthcare Holdings Limited Announces Interim (Semi-Annual) Ordinary Dividend for the Six Months Ended 31 December 2023, Payable on 19 April 2024

UMP Healthcare Holdings Limited Announces Interim (Semi-Annual) Ordinary Dividend for the Six Months Ended 31 December 2023, Payable on 19 April 2024

UMP Healthcare Holdings Limited to Report First Half, 2024 Results on Feb 28, 2024

Co-CEO & Executive Vice Chairman recently bought HK$115k worth of stock

UMP Healthcare Holdings Limited Announces Change of Company Secretary and Authorised Representatives

Co-CEO & Executive Vice Chairman recently bought HK$81k worth of stock

Co-CEO & Executive Vice Chairman recently bought HK$104k worth of stock

UMP Healthcare Holdings (HKG:722) Is Due To Pay A Dividend Of HK$0.03

Upcoming dividend of HK$0.03 per share at 7.2% yield

UMP Healthcare Holdings Limited Announces Board Changes

Executive Chairman recently bought HK$64k worth of stock

Executive Director recently bought HK$67k worth of stock

Full year 2023 earnings released: EPS: HK$0.077 (vs HK$0.092 in FY 2022)

UMP Healthcare Holdings (HKG:722) Is Due To Pay A Dividend Of HK$0.03

UMP Healthcare Holdings Limited Proposes to Declare Final Dividend for the Year Ended 30 June 2023

Executive Chairman recently bought HK$139k worth of stock

Executive Chairman recently bought HK$70k worth of stock

UMP Healthcare Holdings (HKG:722) Is Due To Pay A Dividend Of HK$0.03

UMP Healthcare Holdings Limited, Annual General Meeting, Nov 24, 2023

Full year 2023 earnings released: EPS: HK$0.077 (vs HK$0.092 in FY 2022)

UMP Healthcare Holdings Limited to Report Fiscal Year 2023 Results on Sep 21, 2023

Independent Non-Executive Director recently bought HK$81k worth of stock

Upcoming dividend of HK$0.017 per share at 5.7% yield

Independent Non-Executive Director recently bought HK$79k worth of stock

UMP Healthcare Holdings (HKG:722) Will Pay A Larger Dividend Than Last Year At HK$0.017

First half 2023 earnings released: EPS: HK$0.054 (vs HK$0.059 in 1H 2022)

UMP Healthcare Holdings Limited to Report First Half, 2023 Results on Feb 23, 2023

Now 22% undervalued

UMP Healthcare Holdings Limited Announces Final Dividend for the Financial Year Ended 30 June 2022, Payable on 27 January 2023

Independent Non-Executive Director recently bought HK$80k worth of stock

UMP Healthcare Holdings Limited Announces Retirement of SUN Yiu Kwong as CEO, with Effect from 1 January 2023

Upcoming dividend of HK$0.03 per share

UMP Healthcare Holdings Limited Approves to Declare A Final Dividend for the Year Ended 30 June 2022

Chairman & CEO recently bought HK$111k worth of stock

UMP Healthcare Holdings (HKG:722) Is Increasing Its Dividend To HK$0.03

Less than half of directors are independent

Chairman & CEO recently bought HK$101k worth of stock

UMP Healthcare Holdings Limited Proposes Final Dividend for the Year Ended 30 June 2022, Payable on 27 January 2023

UMP Healthcare Holdings (HKG:722) Will Pay A Larger Dividend Than Last Year At HK$0.03

UMP Healthcare Holdings Limited Proposes Final Dividend for the Year Ended 30 June 2022

Executive Director recently bought HK$72k worth of stock

UMP Healthcare Holdings (HKG:722) Is Increasing Its Dividend To HK$0.03

Third quarter 2022 earnings released: EPS: HK$0.017 (vs HK$0.002 in 3Q 2021)

UMP Healthcare Holdings Limited Proposes Final Dividend for the Year Ended 30 June 2022, Payable on 27 January 2023

UMP Healthcare Holdings Limited Provides Financial Guidance for Fiscal Year 2022

UMP Healthcare Holdings Limited to Report Fiscal Year 2022 Results on Sep 23, 2022

Chairman & CEO recently bought HK$158k worth of stock

Independent Non-Executive Director recently bought HK$155k worth of stock

Here's What To Make Of UMP Healthcare Holdings' (HKG:722) Decelerating Rates Of Return

Less than half of directors are independent

Independent Non-Executive Director recently bought HK$80k worth of stock

Upcoming dividend of HK$0.015 per share

First half 2022 earnings: Revenues and EPS in line with analyst expectations